Nosocomial pneumonia in pediatric patients: Practical problems and rational solutions

Pediatric Drugs

Volumn 4, Issue 2, 2002, Pages 73-83

  Zar, H J ^a   Cotton, M F ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

BURN; CHILD HEALTH CARE; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY POWDER; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; INTUBATION; KLEBSIELLA PNEUMONIAE; METERED DOSE INHALER; MICROBIOLOGICAL EXAMINATION; MORTALITY; NEBULIZER; PEDIATRIC SURGERY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THORAX RADIOGRAPHY; TREATMENT PLANNING;

EID: 0036196898     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204020-00001     Document Type: Review

References (107)

1. Hospital-acquired pneumonia: Perspectives for the healthcare epidemiologist
2. Nosocomial infections in the pediatric intensive care unit
3. Nosocomial pneumonia in children
4. Bacterial nosocomial pneumonia in paediatric intensive care unit
5. Nosocomial infections in pediatric intensive care units in the United States
6. Risk factors for nosocomial infections in a critically ill pediatric population: A 25-month prospective cohort study
7. Risk factors for nosocomial infection in critically ill children: A prospective cohort study
8. Bacterial nosocomial infections in mechanically ventilated children
9. Nosocomial pneumonia: A multivariate analysis of risk and prognosis
10. Neonatal nosocomial infections
11. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: A prospective study
12. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia
13. Nosocomial pulmonary infection: Possible etiologic significance of bacterial adhesion to endotracheal tubes
14. Nosocomial colonisation and infection in a paediatric respiratory intensive care unit
15. Contaminated condensate in mechanical ventilator circuits: A risk factor for nosocomial pneumonia
16. Contaminated medication nebulizers in mechanical ventilator circuits: A source of bacterial aerosol
17. Prolonged use of ventilator circuits and ventilator-associated pneumonia: A model for identifying the optimal clinical practice
18. Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia
19. Weekly ventilator circuit changes: A strategy to reduce costs without affecting pneumonia rate
20. Mechanical ventilation with or without 7-day circuit changes: A randomized controlled study
21. Prevention of nosocomial bacterial pneumonia
22. Nosocomial pneumonia and the role of gastric pH: A meta-analysis
23. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate
24. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: Meta-analysis of randomised controlled trials
25. Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: A comparison of sucralfate and ranitidine
26. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial
27. Nosocomial infections in the intensive care units at a university hospital in a developing country: Comparison with national nosocomial infections surveillance intensive care unit rates
28. Abnormal colonization of neonates in an intensive care unit: Means of identifying neonates at risk of infection
29. Gentamicin vs. cefotaxime for therapy of neonatal sepsis: Relationship to drug resistance
30. Nosocomial infections in pediatric patients with burns
31. Nosocomial infection in pediatric surgical patients: A study of 608 infants and children
32. Nosocomial and community-acquired infections in malnourished children
33. Nosocomial infections in black South African children
34. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit
35. Unique epidemiology of nosocomial infections in a children's hospital
36. Legionella pneumonia in neonates: A literature review
37. Nosocomial pneumonia: Diagnostic and therapeutic considerations
38. Nosocomial legionnaire's disease in a children's hospital
39. Antibiotic-resistant gram-negative bacteria in the critical care setting
40. Antibiotics in neonatal infections: A review
41. Epidemiology of nosocomial infections in pediatric patients
42. Methicillin-resistant Staphylococcus aureus in US hospitals
43. Methicillin-resistant Staphylococcus aureus in Europe
44. Predominant staphylococci in the intensive care unit of a paediatric hospital
45. Beta-lactam antibiotics: Their role in the management of infections in children
46. An outbreak of multiresistant Klebsiella in a neonatal intensive care unit
47. Survey of the prevalence of beta-lactamase amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital
48. Outbreak of multiple resistant enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
49. Epidemiology of antibiotic resistance in human isolates of enterobacteriaceae in Sicily
50. Incidence of anaerobes in ventilator-associated pneumonia using protected specimen brush
51. Nosocomial pneumonia with isolation of anaerobic bacteria patients: Therapeutic considerations and outcome
52. Nosocomial respiratory syncytial virus infections: The cost-effectiveness and cost-benefit of infection control
53. Hospital-acquired pneumonia in children: The role of respiratory viruses
54. Clinical characteristics of parainfluenza virus infection in hospitalized children
55. Outbreak of parainfluenza virus type 3 in a neonatal nursery
56. Nosocomial adenovirus infection in a paediatric respiratory unit
57. An outbreak of Pneumocystis carinii pneumonia in children with malignancy
58. Review of case definitions for nosocomial infection: Towards a consensus
59. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy and preventative strategies: A consensus statement
60. Laboratory diagnosis of nosocomial pneumonia
61. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa
62. Endotracheal aspiration for the bacteriological diagnosis of nosocomial- and measles-associated pneumonia
63. Nonbronchoscopic bronchoalveolar lavage in mechanically ventilated infants: Technique, efficacy and applications
64. Blind protected specimen brush and bronchoalveolar lavage in ventilated children
65. Nosocomial bacterial pneumonia in ventilated children: Clinical significance of culture-positive peripheral bronchial aspirates
66. Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia
67. Microbiological considerations of the etiological agents of lower respiratory tract infections
68. New approaches in the diagnosis of nosocomial pneumonia
69. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia
70. Usefulness of quantitative cultures of BAL fluid for diagnosing nosocomial pneumonia in ventilated patients
71. Validation of different techniques for the diagnosis of ventilator associated pneumonia: Comparison with immediate post-mortem biopsy
72. Reappraisal of lung tap: Review of an old method for better etiologic diagnosis of childhood pneumonia
73. Paediatric bacteraemia in the South-Western Cape
74. Nosocomial respiratory infections
75. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia
76. Nosocomial pneumonia: Blood cultures remain useful
77. The diagnosis and treatment challenges in nosocomial pneumonia
78. A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital
79. Selecting therapy for serious infections in children: Maximising safety and efficacy
80. Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections
81. A prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis
82. Piperacillin/tazobactam: An updated review of its use in the treatment of bacterial infections
83. The treatment of respiratory Pseudomonas infection in cystic fibrosis: What drug and which way
84. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolised colistin
85. Inhaled antimicrobial therapy
86. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria
87. Drug treatment of pneumonia in the hospital: What are the choices?
88. Antimicrobial therapy and related agents
89. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
90. Staphylococcal infections
91. Antimicrobial resistance in staphylococci
92. Respiratory syncytial virus
93. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1
94. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab update on the use of RSV-IGIV
95. Nosocomial respiratory virus infections: The "cold war" has not ended
96. The use of palivizumab monoclonal antibody to control an outbreak of nosocomial respiratory syncytial virus infection in a special care baby unit
97. Decreased transmission of enterobacteriaceae with extended spectrum β-lactamases in an intensive care unit by nursing reorganization
98. Nosocomial infections in a neonatal intensive care unit
99. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position
100. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
101. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: Potential economic implications
102. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomized controlled trials
103. Opinion: The clinical use of selective digestive decontamination
104. Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings
105. An antibiotic policy to prevent the emergence of resistant bacilli
106. Use of antibiotics in pediatric intensive care and potential savings